| 1 |
20931328 | Disruption of opioid-induced placebo responses by activation of cholecystokinin type-2 receptors. | 2011 Feb |
1 |
| 2 |
18214880 | Synthesis of a novel pentagastrin-drug conjugate for a targeted tumor therapy. | 2008 |
1 |
| 3 |
18222546 | Effect of time of preparation on pentagastrin-induced symptom, endocrine and cardiovascular responses. | 2008 Mar 15 |
1 |
| 4 |
17536796 | Optimization of 1,3,4-benzotriazepine-based CCK(2) antagonists to obtain potent, orally active inhibitors of gastrin-mediated gastric acid secretion. | 2007 Jun 28 |
1 |
| 5 |
15001623 | Cholecystokinin (CCK) stimulates aldosterone secretion from human adrenocortical cells via CCK2 receptors coupled to the adenylate cyclase/protein kinase A signaling cascade. | 2004 Mar |
4 |
| 6 |
15157745 | Effect of repeat exposure on neuroendocrine and symptom responses to pentagastrin. | 2004 May 30 |
2 |
| 7 |
15219640 | Effects of propranolol on symptom and endocrine responses to pentagastrin. | 2004 Oct |
1 |
| 8 |
12510010 | Hypothalamic-pituitary adrenal response to cholecystokinin-B receptor agonism is resistant to cortisol feedback inhibition. | 2003 Feb |
1 |
| 9 |
12529809 | Pentagastrin test for anxiety--psychophysiology and personality. | 2003 Mar |
1 |
| 10 |
12865901 | Pulmonary and systemic nitric oxide measurements during CCK-5-induced panic attacks. | 2003 Oct |
1 |
| 11 |
12073167 | Anxiogenic effects of the CCK(B) agonist pentagastrin in humans and dose-dependent increase in plasma C-peptide levels. | 2002 Jun |
3 |
| 12 |
11120398 | Dose response of arginine vasopressin to the CCK-B agonist pentagastrin. | 2001 Feb |
1 |
| 13 |
11713976 | Cholecystokinin and panic disorder: past and future clinical research strategies. | 2001 |
1 |
| 14 |
11078001 | The effect of a cholecystokinin agonist on masseter muscle activity in the cat. | 2000 Oct |
3 |
| 15 |
10481831 | Dose response of adrenocorticotropin and cortisol to the CCK-B agonist pentagastrin. | 1999 Oct |
2 |
| 16 |
9689451 | Cholecystokinin B receptors in the periaqueductal gray potentiate defensive rage behavior elicited from the medial hypothalamus of the cat. | 1998 Jun 15 |
1 |
| 17 |
9137133 | Effects of the cholecystokinin agonist pentagastrin in patients with generalized anxiety disorder. | 1997 May |
1 |
| 18 |
23338219 | Cholecystokinin and psychiatric disorders : role in aetiology and potential of receptor antagonists in therapy. | 1997 Aug |
1 |
| 19 |
8782652 | Unexpected high incidence of cholecystokinin-B/gastrin receptors in human medullary thyroid carcinomas. | 1996 Sep 4 |
1 |
| 20 |
8891258 | Intracerebroventricular infusion of the CCKB receptor agonist pentagastrin potentiates acoustic startle. | 1996 Sep 9 |
1 |
| 21 |
26964658 | The role of the 'central' cholecystokinin-B receptor in panic disorder. | 1996 Dec |
1 |
| 22 |
7619662 | Cholecystokinin and anxiety in normal volunteers: an investigation of the anxiogenic properties of pentagastrin and reversal by the cholecystokinin receptor subtype B antagonist L-365,260. | 1995 Mar |
2 |
| 23 |
9160584 | Peptides and anxiety: a dose-response evaluation of pentagastrin in healthy volunteers. | 1994-1995 |
1 |